I’ve started and led multiple innovation departments across industries. Each time, the pattern is eerily similar: what begins with bold intent and bright minds slowly sours into organizational resistance, misalignment, and, eventually, disillusionment. Why? That is because disruptive innovation, if not structurally and culturally contained, acts like an infection to traditional enterprises.
It doesn’t matter how advanced your technology is or how creative your team might be. If the CEO isn’t intimately involved, and if the reward systems don’t align, then your innovation efforts are doomed to be dismissed as “interesting experiments” rather than engines of future growth.
Let me explain why.
Disruption Is Not Just Change; It's Structural Shock
Geoffrey Moore in Zone to Win offers a brilliant diagnosis: large enterprises are optimized for execution, not innovation. They are built to protect and scale proven business models, not to test unproven ones. So, when a disruptive initiative is introduced, it doesn’t integrate; it irritates. It challenges metrics, resource flows, power structures, and cultural norms. It feels like a foreign body.
This is why Moore proposes the four-zone model—Performance, Productivity, Incubation, and Transformation. Without clearly delineating where and how disruption is supposed to thrive, the core business immune system will always treat it as a threat and crush it.
Innovation Without Leadership Antibodies Is Toxic
I’ve seen this firsthand: teams spinning up moonshot projects, only to find themselves measured by the same KPIs as a legacy product line. Or middle managers praising “agility” while withholding budget unless the innovation guarantees ROI in six months.
Here’s the brutal truth: If the CEO is not leading the transformation, then it won’t happen. Innovation is not something that can be delegated. It needs to be sponsored, resourced, and protected by the highest level of leadership.
And leadership must go beyond verbal support; it must include structural support:
- Changing incentive models
- Shielding disruptive teams from legacy P&L scrutiny
- Championing one "bet" at a time (as Moore emphasizes in the Transformation Zone)
Culture Eats Innovation for Breakfast
Clayton Christensen warned us in The Innovator’s Dilemma that companies fail not because they don’t see disruption coming, but because they are too successful at doing what they’ve always done.
Incentives are the clearest expression of what a company actually values. If promotions, raises, and recognition come from hitting operational goals—not from bold experimentation—then guess where your best people will focus?
If innovation is a side gig, then it stays on the side. If it’s a “zone” with no career path, then it becomes a dead end.
Disruption as Designed Infection—With Containment
So, yes, disruption is an infection. But not all infections are bad. The key is controlled exposure. Like a vaccine, the right dose in the right zone can strengthen the organization. But if you inject disruption directly into the core, unbuffered, it will trigger resistance—or worse, rejection.
That’s why the most successful innovation programs I’ve helped build do three things:
1
Secure C-suite sponsorship from Day 1—especially the CEO
2
Design org models that protect innovation zones from legacy KPIs
3
Tie career and compensation incentives to long-term learning, not just short-term delivery
Final Thought
Disruptive innovation is not just a creative endeavor. It’s a political, structural, and cultural one. And if you’re not ready to restructure part of your organization—and your reward systems—then you’re not ready to innovate.
If you’re a leader reading this, ask yourself: Are you incubating innovation or immunizing your company against it?
Let’s build systems where the future has a real chance to grow.
